227 related articles for article (PubMed ID: 7004099)
21. Assessment of teratogenic potential of therapeutic agents: preclinical toxicology.
Frederick GL
Clin Invest Med; 1985; 8(4):323-7. PubMed ID: 4075617
[TBL] [Abstract][Full Text] [Related]
22. The complexities of solving the problem of human malformations.
Brent RL
Clin Perinatol; 1986 Sep; 13(3):491-503. PubMed ID: 3533363
[TBL] [Abstract][Full Text] [Related]
23. Regulatory aspects of teratology: role of the Food and Drug Administration.
Kelsey FO
Teratology; 1982 Apr; 25(2):193-9. PubMed ID: 7048616
[TBL] [Abstract][Full Text] [Related]
24. Reply to "Prenatal exposure to sex hormones: a case-control study".
Li DK
Teratology; 1998 Jul; 58(1):1. PubMed ID: 9699237
[No Abstract] [Full Text] [Related]
25. Are female sex hormones teratogenic?
Wilson JG; Brent RL
Am J Obstet Gynecol; 1981 Nov; 141(5):567-80. PubMed ID: 6271011
[TBL] [Abstract][Full Text] [Related]
26. [Use of sex hormones in pregnancy in Spain 1976-1984].
García Alonso F; Rodríguez Pinilla E; Martínez Frías ML; Marcos Herrero F; Salvador J; Levy Mafhoda M; Dal Re Saavedra M
Med Clin (Barc); 1988 Feb; 90(5):183-5. PubMed ID: 3352360
[No Abstract] [Full Text] [Related]
27. Methods for predicting human birth defects.
Clayson DB
Prog Clin Biol Res; 1985; 163C():197-203. PubMed ID: 3991622
[No Abstract] [Full Text] [Related]
28. Exogenous female sex hormones and birth defects.
Polednak AP
Public Health Rev; 1985; 13(1-2):89-114. PubMed ID: 2939493
[No Abstract] [Full Text] [Related]
29. Thrombosis and sex hormones: a perplexing liaison.
Wessler S
J Lab Clin Med; 1980 Nov; 96(5):757-61. PubMed ID: 6999103
[TBL] [Abstract][Full Text] [Related]
30. Women in clinical trials.
Merkatz RB; Temple R
Oncology (Williston Park); 1994 Jun; 8(6):52, 57. PubMed ID: 8074983
[No Abstract] [Full Text] [Related]
31. Systematic identification of drugs that cause birth defects--a new opportunity.
Mitchell AA
N Engl J Med; 2003 Dec; 349(26):2556-9. PubMed ID: 14695418
[No Abstract] [Full Text] [Related]
32. [Adverse effects of steroid sex hormones].
Hirschler I
Orv Hetil; 1977 Aug; 118(34):2061-3. PubMed ID: 561936
[No Abstract] [Full Text] [Related]
33. Reproductive toxicology guidelines: comparison and application.
Beltrame D; Mazué G
Ann Ist Super Sanita; 1993; 29(1):3-14. PubMed ID: 8129269
[TBL] [Abstract][Full Text] [Related]
34. Case-control studies on the effect of sex steroids on women and their offspring.
Janerich DT; Glebatis D; Flink E; Hoff MB
J Chronic Dis; 1979; 32(1-2):83-8. PubMed ID: 312806
[No Abstract] [Full Text] [Related]
35. Oral contraceptives and estrogen combinations (excluding progestogens) during the first trimester--clearly increased the risk of overall birth defects.
Martínez-Frías ML; Rodríguez-Pinilla E; Bermejo E; Prieto L
Teratology; 1998 Aug; 58(2):29. PubMed ID: 9787403
[No Abstract] [Full Text] [Related]
36. Current status of drugs as teratogens in man.
Schardein JL
Prog Clin Biol Res; 1985; 163C():181-90. PubMed ID: 3921982
[TBL] [Abstract][Full Text] [Related]
37. Drug use during pregnancy in Hungary.
Czeizel A
Acta Med Hung; 1989; 46(1):53-62. PubMed ID: 2771584
[TBL] [Abstract][Full Text] [Related]
38. Teratogens in the human: current problems.
Hawkins DF
J Clin Pathol Suppl (R Coll Pathol); 1976; 10():150-6. PubMed ID: 1067266
[No Abstract] [Full Text] [Related]
39. Birth defect surveillance in the search for and evaluation of possible human teratogens.
Oakley GP
J Environ Pathol Toxicol; 1978; 2(1):211-6. PubMed ID: 722223
[No Abstract] [Full Text] [Related]
40. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
Brent RL
Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
